Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
Bausch & Lomb, Inc. |
---|---|
Information provided by: | Bausch & Lomb, Inc. |
ClinicalTrials.gov Identifier: | NCT00347594 |
The purpose of this study is to measure the aberrations, corneal surface topography and pachymetry of normal human eyes with the NGDI.
Condition | Intervention |
---|---|
Healthy |
Device: NGDI |
Study Type: | Observational |
Study Design: | Prospective |
Ages Eligible for Study: | 21 Years to 75 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Exclusion Criteria:
Study ID Numbers: | GVC2-03-052 |
Study First Received: | June 30, 2006 |
Last Updated: | November 27, 2007 |
ClinicalTrials.gov Identifier: | NCT00347594 History of Changes |
Health Authority: | United States: Institutional Review Board |
Corneal surface topography and ocular aberrations. |
Healthy |